Glycopyrronium Bromide 200micrograms/ml Solution for Injection Malta - English - Medicines Authority

glycopyrronium bromide 200micrograms/ml solution for injection

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - glycopyrronium bromide - solution for injection - glycopyrronium bromide 200 µg/ml - drugs for functional gastrointestinal disorders

Glycopyrronium Bromide 200 micrograms per ml Solution for Injection Malta - English - Medicines Authority

glycopyrronium bromide 200 micrograms per ml solution for injection

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - glycopyrronium bromide - solution for injection - glycopyrronium bromide 200 µg/ml - drugs for functional gastrointestinal disorders

Glycopyrronium Bromide 200 micrograms per ml Solution for Injection Malta - English - Medicines Authority

glycopyrronium bromide 200 micrograms per ml solution for injection

health house pharma ltd t/as p&d pharmaceuticals ltd 38 woolmer way, bordon, hampshire, gu35 9q, united kingdom - glycopyrronium bromide - solution for injection - glycopyrronium bromide 200 µg/ml - drugs for functional gastrointestinal disorders

Glycopyrronium Bromide Solution for injection 200 mcg Tanzania - English - Tanzania Medicinces & Medical Devices Authority

glycopyrronium bromide solution for injection 200 mcg

martindale pharma, united kingdom - glycopyrronium bromide - solution for injection - 200 mcg

Glycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg/2.5mg per mL New Zealand - English - Medsafe (Medicines Safety Authority)

glycopyrronium bromide and neostigmine metilsulfate 0.5mg/2.5mg per ml

boucher & muir (nz) ltd t/a mercury pharma (nz) - glycopyrronium bromide 0.5 mg/ml; neostigmine metilsulfate 2.5 mg/ml - solution for injection - active: glycopyrronium bromide 0.5 mg/ml neostigmine metilsulfate 2.5 mg/ml excipient: citric acid citric acid monohydrate dibasic sodium phosphate dodecahydrate sodium hydroxide water for injection - reversal of residual non-depolarising (competitive) neuromuscular block.

ULTIBRO BREEZHALER 110/50 indacaterol (as maleate)/ glycopyrronium (as bromide) 110 microgram / 50 microgram powder for inhalation in hard capsule Australia - English - Department of Health (Therapeutic Goods Administration)

ultibro breezhaler 110/50 indacaterol (as maleate)/ glycopyrronium (as bromide) 110 microgram / 50 microgram powder for inhalation in hard capsule

novartis pharmaceuticals australia pty ltd - glycopyrronium bromide, quantity: 63 microgram (equivalent: glycopyrronium, qty 50 microgram); indacaterol maleate, quantity: 143 microgram (equivalent: indacaterol, qty 110 microgram) - inhalation, powder for - excipient ingredients: lactose monohydrate; magnesium stearate - ultibro breezhaler 110/50 is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in patients with chronic obstructive pulmonary disease (copd), and for the reduction of exacerbations of copd in patients with a history of exacerbations.

SEEBRI BREEZHALER glycopyrronium (as bromide) 50 microgram powder for inhalation (in capsule) blister Australia - English - Department of Health (Therapeutic Goods Administration)

seebri breezhaler glycopyrronium (as bromide) 50 microgram powder for inhalation (in capsule) blister

novartis pharmaceuticals australia pty ltd - glycopyrronium bromide, quantity: 63 microgram (equivalent: glycopyrronium, qty 50 microgram) - inhalation, powder for - excipient ingredients: hypromellose; carrageenan; potassium chloride; magnesium stearate; purified water; sunset yellow fcf; lactose monohydrate; strong ammonia solution; ethanol absolute; propylene glycol; potassium hydroxide; butan-1-ol; shellac; iron oxide black; isopropyl alcohol - seebri breezhaler is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (copd).

NOVISTIG glycopyrronium bromide (glycopyrrolate)/neostigmine methylsulfate 0.5 mg/2.5 mg per 1 mL injection solution ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

novistig glycopyrronium bromide (glycopyrrolate)/neostigmine methylsulfate 0.5 mg/2.5 mg per 1 ml injection solution ampoule

boucher & muir pty ltd - neostigmine methylsulfate, quantity: 2.5 mg; glycopyrronium bromide, quantity: 0.5 mg - injection, solution - excipient ingredients: water for injections; citric acid; dibasic sodium phosphate dodecahydrate; sodium hydroxide - reversal of residual non-depolarising (competitive) neuromuscular block.

GLYCONEO 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/neostigmine methylsulfate 2.5 mg in 1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

glyconeo 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/neostigmine methylsulfate 2.5 mg in 1 ml solution for injection ampoule

ksj pharmatech - neostigmine methylsulfate, quantity: 2.5 mg; glycopyrronium bromide, quantity: 0.5 mg - injection, solution - excipient ingredients: water for injections; citric acid; sodium hydroxide; dibasic sodium phosphate dodecahydrate - reversal of residual non-depolarising (competitive) neuromuscular block.

DBL GLYCOPYRROLATE INJECTION glycopyrronium bromide (glycopyrrolate) 0.2 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

dbl glycopyrrolate injection glycopyrronium bromide (glycopyrrolate) 0.2 mg/1 ml solution for injection ampoule

pfizer australia pty ltd - glycopyrronium bromide (glycopyrrolate) -